The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Compounds · Other compounds

Research-use-only status: what it means legally and practically — does this still hold?

Solved Pinned
Solved by e.tamm in post #2
Several compounds discussed here have no published human pharmacokinetics at all. That means half-life claims in circulation were derived from an animal model or from nothing.

Jump to the accepted answer →

DB
dr_bhattacharyaTL3Physician7 Apr 2025#1

Asking directly, because I could not find a straight answer: Research-use-only status: what it means legally and practically — does this still hold?

Asking about Research-use-only status directly, because I have read four threads on it and each answered a slightly different question.

The version I want answered is the narrow one: given the method stated below, is the result within what anyone else has seen? I am not asking what it means yet.

Method, numbers and the two assumptions I am aware of making are below. If the assumptions are wrong that is more useful to me than agreement.

21 likes 16mo
ET
e.tammTL2 Solution30 Jul 2025#2

Several compounds discussed here have no published human pharmacokinetics at all. That means half-life claims in circulation were derived from an animal model or from nothing.

24 likes 12mo
RT
r.torrenceTL2Member21 Oct 2025#3

Narrowing post #2, because the general version has more than one answer.

Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or treatment. The label does not tell you whether the molecule is safe, efficacious, or what its effects are.

Take it as a starting point and not as a specification.

0 likes 9mo

Suggested topics

TopicParticipantsRepliesViewsActivity
About the Other compounds category
Anything not covered by a dedicated subcategory, including research-use-only material with no human data. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
KJMMYSDK+8 12 51k 7mo
Sequence verification for an obscure compound: how it is done — what changed since
On the subject in the title: Sequence verification for an obscure compound: how it is done — what changed since Working notes rather than a conclusion. What changes if the standard account of Sequence…
TNDBSOLGHF+100 108 1.3k 8mo
AOD-9604 and the fragment hypothesis, revisited
Posting this under the heading it deserves: AOD-9604 and the fragment hypothesis, revisited Everything below is what sits behind that. Reading back through what has been written here about AOD-9604, three…
ARCDJBMRBR+40 44 2.8k 6mo
Compounds this community declines to help with, and why
Compounds this community declines to help with, and why — setting out what I have, and where I think it stops being reliable. Putting the numbers in the first post, because a question about a compound without…
MKJSMSRFF+81 87 35k 10mo
Sequence verification for an obscure compound: how it is done
Sequence verification for an obscure compound: how it is done Writing it up because I had to work it out twice and would rather nobody else did. Asking about sequence verification directly, because I have…
BNGVIAJVGE+104 114 10k 12mo

Related topics — sharing the tags custom synthesis, mislabelling, needs a source

TopicParticipantsRepliesViewsActivity
Stability of BPC-157 in solution: what has been measured
Stability of BPC-157 in solution: what has been measured — setting out what I have, and where I think it stops being reliable. Something about stability of BPC-157 does not reconcile and I would like a second…
AKEFSS 2 805 30d
Melanocortin agonists: mechanism and the documented adverse profile
Melanocortin agonists: mechanism and the documented adverse profile — setting out what I have, and where I think it stops being reliable. Melanocortin agonists, and specifically the version of it that the…
APAWCEBWGR+7 11 5.5k 20mo
Levothyroxine timing: a real interaction with a simple fix
Levothyroxine timing: a real interaction with a simple fix Writing it up because I had to work it out twice and would rather nobody else did. A narrow question about levothyroxine timing, deliberately narrow,…
ABITMSBVNL+20 24 60k 18mo
A widely repeated interaction claim that turns out to be unsupported
On the subject in the title: A widely repeated interaction claim that turns out to be unsupported Working notes rather than a conclusion. I was wrong about widely repeated interaction claim in a thread last…
NKRGBNMSDT+47 51 37k 3mo
Naming conventions for research peptides and the confusion they cause — one year on
Naming conventions for research peptides and the confusion they cause — one year on — setting out what I have, and where I think it stops being reliable. Asking about Naming conventions for research peptides…
CPLCVSMSCV+1 5 181 2y